Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001415889-24-008975

Options or other derivatives

  • CHIEF COMMERCIAL OFFICER acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Evanson Jeff CHIEF COMMERCIAL OFFICER 2024-03-20 Grant or award · Stock Option (Right to Buy) +25,000 25,000 D
Loading xslF345X05/form4-03222024_050317.xml…